AUTUMN FEAZELL: Open Payments
NPI 1134493125 · OAK HILL, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,741 in 72 payments from 13 companies in 2025. Trend: 2023 $1,641 · 2024 $1,088 · 2025 $1,741
Food & beverage: $1,741
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $326 |
| Ardelyx, Inc. | 16 | $284 |
| Celltrion USA Inc. | 18 | $260 |
| Novo Nordisk Inc | 2 | $176 |
| GENZYME CORPORATION | 7 | $168 |
| Madrigal Pharmaceuticals | 1 | $100 |
| Lilly USA, LLC | 1 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $89 |
| Ipsen Biopharmaceuticals, Inc | 1 | $88 |
| Janssen Biotech, Inc. | 1 | $83 |
Products named: RINVOQ, IBSRELA, DUPIXENT, VEGZELMA, Ozempic, ZYMFENTRA, REZDIFFRA, ENTYVIO.
Industry payments across WV — which companies pay providers there.
